Literature DB >> 821403

Comparative toxicity of gold preparations in treatment of rheumatoid arthritis.

J S Lawrence.   

Abstract

Patients with rheumatoid arthritis have been treated alternately with aurothioglucose and aurothiomalate. In the earlier part of the study an oily suspension of aurothioglucose and an aqueous solution of aurothiomalate were used, but later an aqueous solution of aurothioglucose was alternated with the oily suspension and an oily suspension of aurothiomalate with the aqueous solution. Skin eruptions, stomatitis, and albuminuria were significantly more common in patients treated with the aqueous solution than with the oily suspension.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 821403      PMCID: PMC1006532          DOI: 10.1136/ard.35.2.171

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  2 in total

1.  Factors in gold dosage and toxicity in rheumatoid arthritis.

Authors:  J S LAWRENCE
Journal:  Ann Rheum Dis       Date:  1953-06       Impact factor: 19.103

2.  Gold excretion correlated with clinical course during chrysotherapy in rheumatoid arthritis.

Authors:  N L Gottlieb; P M Smith; E M Smith
Journal:  Arthritis Rheum       Date:  1972 Nov-Dec
  2 in total
  2 in total

1.  Aurothioglucose overdosage in five patients with rheumatoid arthritis.

Authors:  I Rubinstein; P Langevitz; M Pras
Journal:  Clin Rheumatol       Date:  1987-12       Impact factor: 2.980

Review 2.  Antirheumatic drugs: clinical pharmacology and therapeutic use.

Authors:  G L Craig; W W Buchanan
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.